Clinical Trial Update: A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD） [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing LY09004 with Eylea for wet age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• EYLEA (Aflibercept)
• LY09004

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Age Related Macular Degeneration | Phase 3 | Status: UNKNOWN